Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes

Archive ouverte

Binder, Moritz | Szalat, Raphael | Talluri, Srikanth | Fulciniti, Mariateresa | Avet-Loiseau, Hervé | Parmigiani, Giovanni | Samur, Mehmet | Munshi, Nikhil

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract The natural history of multiple myeloma is characterized by its localization to the bone marrow and its interaction with bone marrow stromal cells. The bone marrow stromal cells provide growth and survival signals, thereby promoting the development of drug resistance. Here, we show that the interaction between bone marrow stromal cells and myeloma cells (using human cell lines) induces chromatin remodeling of cis-regulatory elements and is associated with changes in the expression of genes involved in the cell migration and cytokine signaling. The expression of genes involved in these stromal interactions are observed in extramedullary disease in patients with myeloma and provides the rationale for survival of myeloma cells outside of the bone marrow microenvironment. Expression of these stromal interaction genes is also observed in a subset of patients with newly diagnosed myeloma and are akin to the transcriptional program of extramedullary disease. The presence of such adverse stromal interactions in newly diagnosed myeloma is associated with accelerated disease dissemination, predicts the early development of therapeutic resistance, and is of independent prognostic significance. These stromal cell induced transcriptomic and epigenomic changes both predict long-term outcomes and identify therapeutic targets in the tumor microenvironment for the development of novel therapeutic approaches.

Consulter en ligne

Suggestions

Du même auteur

Development of hyperdiploidy starts at an early age and takes a decade to complete

Archive ouverte | Samur, Mehmet | CCSD

International audience. Abstract Nearly half of patients with multiple myeloma (MM) have hyperdiploidy (HMM) at diagnosis. Although HMM occurs early, the mutational processes before and after hyperdiploidy are still...

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

Archive ouverte | Samur, Mehmet Kemal | CCSD

International audience. Abstract High-dose melphalan (HDM) improves progression-free survival in multiple myeloma (MM), yet melphalan is a DNA-damaging alkylating agent; therefore, we assessed its mutational effect ...

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Archive ouverte | Bazarbachi, Abdul Hamid | CCSD

International audience. Abstract Immunoglobulin M (IgM) multiple myeloma (MM) is a rare disease subgroup. Its differentiation from other IgM-producing gammopathies such as Waldenström macroglobulinemia (WM) has not ...

Chargement des enrichissements...